An administrative error leads to 597 CEO shares withheld for tax at Monopar Therapeutics (MNPR).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Monopar Therapeutics (MNPR) reported that 597 common shares belonging to CEO Chandler Robinson were withheld on October 20, 2026, to cover withholding tax. This withholding was due to an administrative error related to the vesting and settlement of 12,873 restricted stock units on June 30, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.